🐜
|
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.
78 auth.
R. Clarke,
R. Collins,
S. Lewington,
A. Donald,
G. Alfthan,
J. Tuomilehto,
E. Arnesen,
K. Bønaa,
J. Blacher,
G. Boers,
A. Bostom,
M. Bots,
D. Grobbee,
L. Brattström,
M. Breteler,
...
A. Hofman,
J. Chambers,
J. Kooner,
B. Coull,
R. W. Evans,
L. Kuller,
S. Evers,
A. Folsom,
G. Freyburger,
F. Parrot,
J. Genest,
K. Dalery,
I. Graham,
L. Daly,
E. Hoogeveen,
P. Kostense,
C. Stehouwer,
P. Hopkins,
P. Jacques,
J. Selhub,
F. Luft,
P. Jungers,
A. Lindgren,
Y. Lolin,
F. Loehrer,
B. Fowler,
M. A. Mansoor,
M. Malinow,
P. Ducimetiere,
O. Nygård,
H. Refsum,
S. Vollset,
P. Ueland,
G. Omenn,
S. Beresford,
J. Roseman,
H. Parving,
M. Gall,
I. Perry,
S. Ebrahim,
A. Shaper,
K. Robinson,
D. Jacobsen,
S. Schwartz,
D. Siscovick,
M. Stampfer,
C. Hennekens,
E. Feskens,
D. Kromhout,
J. Ubbink,
P. Elwood,
J. Pickering,
P. Verhoef,
A. Eckardstein,
H. Schulte,
G. Assmann,
N. Wald,
M. Law,
P. Whincup,
D. Wilcken,
P. Sherliker,
P. Linksted,
G. Smith
|
10 |
2002 |
10 🐜
|
🐜
|
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
8 auth.
G. Watts,
P. Barrett,
J. Ji,
A. Serone,
D. Chan,
K. Croft,
...
F. Loehrer,
A. Johnson
|
7 |
2003 |
7 🐜
|
🐜
|
Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double‐blind, placebo‐controlled study
9 auth.
J. Rimmer,
H. Peake,
C. Santos,
M. Lean,
P. Bardin,
R. Robson,
...
B. Haumann,
F. Loehrer,
M. Handel
|
5 |
2007 |
5 🐜
|
🐬
|
Effect of low doses of 5‐methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C→T polymorphism of methylenetetrahydrofolate reductase
P. Lityński,
F. Loehrer,
L. Linder,
L. Todesco,
B. Fowler
|
5 |
2002 |
5 🐬
|
🐬
|
W09.204 Fenofibrate increases HDL LPAI-AII production in men with the metabolic syndrome
H. Barrett,
J. Ji,
A. Johnson,
A. Serone,
F. Loehrer,
G. Watts
|
0 |
2004 |
0 🐬
|
🦁
|
Clinical outcome of multimodal rehabilitative care for young patients with multiple drug abuse
F. Loehrer,
R. Sotho-Loewenthal,
Hanns-Jürgen Kunert
|
0 |
2007 |
0 🦁
|
🐢
|
P03-218 - Effects Of Specific Attentiveness Training In Young Schizophrenic Patients With Multiple Drug Abuse
H.J. Kunert,
F. Loehrer
|
0 |
2010 |
0 🐢
|
🐜
|
3P-0778 Kinetics of HDL apoAI and apoAII in the metabolic syndrome
7 auth.
J. Ji,
H. Barrett,
A. Johnson,
D. Chan,
A. Serone,
F. Loehrer,
...
G. Watts
|
0 |
2003 |
0 🐜
|
🦁
|
P0034 - Neurocognitive function deficits and drug abuse: Specific forms of intoxication
F. Loehrer,
H.J. Kunert
|
0 |
2008 |
0 🦁
|
🐢
|
Effects of multiple drug abuse on attentional functioning - the impact of substance abuse, psychiatric disorder and time of abstinence
H.J. Kunert,
F. Loehrer
|
0 |
2007 |
0 🐢
|
🐢
|
P0218 - Neuroscientific aspects of chronic Cannabis use: Impact on development, cognitive performance and psychiatric disorders
H.J. Kunert,
F. Loehrer
|
0 |
2008 |
0 🐢
|